Skip to content
ppharmaranks
Menu

BENICAR vs OLMESARTAN MEDOXOMIL

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 14, 2026·How we rate

Rating

70/100
68/100

Pharmacy pays

~$2.24 /30
~$2.24 /30

Type

RX
RX

Active ingredient

OLMESARTAN MEDOXOMIL
OLMESARTAN MEDOXOMIL

Manufacturer

Dosage forms

Tablet
Tablet

Drug class

Angiotensin 2 Receptor Blocker
Angiotensin 2 Receptor Blocker

Boxed warning

Treats

Diabetic Nephropathies, Heart Failure, Hypertension
Diabetic Nephropathies, Heart Failure, Hypertension

Get benicarhigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

Frequently asked questions

Which is better-rated, Benicar or Olmesartan Medoxomil?

By our independent rating, Benicar scores higher — 3.5 vs 3.4 out of 5 for Olmesartan Medoxomil. Ratings are based on FDA regulatory (recall-safety) data.

Which is cheaper, Benicar or Olmesartan Medoxomil?

Pharmacies pay about the same to acquire either one — roughly $2.24 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.

What is the difference between Benicar and Olmesartan Medoxomil?

Both Benicar and Olmesartan Medoxomil share the active ingredient Olmesartan Medoxomil.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.